LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | XMD16-144 | 0.37 | uM | LJP5 | 3 | M10 | 72 | hr | 868 | 1237 | 3486 | 0.3548 | 0.1409 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 868 | 2793 | 3486 | 0.8011 | 0.7352 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 868 | 3232 | 3486 | 0.9270 | 0.9028 |
MDA-MB-231 | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 868 | 2878 | 3486 | 0.8255 | 0.7676 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 868 | 2633 | 3486 | 0.7552 | 0.6741 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 868 | 2776 | 3486 | 0.7962 | 0.7287 |
MDA-MB-231 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 868 | 2964 | 3486 | 0.8502 | 0.8005 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 1 | L22 | 72 | hr | 868 | 2730 | 3486 | 0.7830 | 0.7111 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 2 | L22 | 72 | hr | 868 | 3081 | 3486 | 0.8837 | 0.8452 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 3 | L22 | 72 | hr | 868 | 3070 | 3486 | 0.8806 | 0.8410 |
MDA-MB-231 | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 868 | 2923 | 3486 | 0.8384 | 0.7848 |
MDA-MB-231 | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 868 | 3358 | 3486 | 0.9632 | 0.9510 |
MDA-MB-231 | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 868 | 3206 | 3486 | 0.9196 | 0.8929 |
MDA-MB-231 | Celastrol | 0.37 | uM | LJP6 | 1 | G10 | 72 | hr | 868 | 2101 | 3486 | 0.6026 | 0.4709 |
MDA-MB-231 | Celastrol | 0.37 | uM | LJP6 | 2 | G10 | 72 | hr | 868 | 1963 | 3486 | 0.5631 | 0.4182 |
MDA-MB-231 | Celastrol | 0.37 | uM | LJP6 | 3 | G10 | 72 | hr | 868 | 1952 | 3486 | 0.5599 | 0.4140 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 1 | F04 | 72 | hr | 868 | 717 | 3486 | 0.2057 | -0.0577 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 2 | F04 | 72 | hr | 868 | 622 | 3486 | 0.1784 | -0.0940 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 3 | F04 | 72 | hr | 868 | 748 | 3486 | 0.2146 | -0.0459 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 1 | G04 | 72 | hr | 868 | 824 | 3486 | 0.2364 | -0.0169 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 2 | G04 | 72 | hr | 868 | 835 | 3486 | 0.2395 | -0.0126 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP6 | 3 | G04 | 72 | hr | 868 | 765 | 3486 | 0.2194 | -0.0394 |
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 1 | P16 | 72 | hr | 868 | 2708 | 3486 | 0.7767 | 0.7027 |
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 2 | P16 | 72 | hr | 868 | 2942 | 3486 | 0.8439 | 0.7921 |
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 3 | P16 | 72 | hr | 868 | 3091 | 3486 | 0.8866 | 0.8490 |